1. A New Method to Model and Predict Progression Free Survival Based on Tumor Growth Dynamics. (12th March 2020) Authors: Yu, Jiajie; Wang, Nina; Kågedal, Matts Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 3(2020) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of Longitudinal‐Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models. (30th January 2020) Authors: Lu, Tong; Yang, Yujie; Jin, Jin Y.; Kågedal, Matts Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 2(2020) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autoradiographic Mapping of 5-HT1B/1D Binding Sites in the Rhesus Monkey Brain Using [carbonyl-11C]zolmitriptan. (12th October 2011) Authors: Lindhe, Örjan; Almqvist, Per; Kågedal, Matts; Gustafsson, Sven-Åke; Bergström, Mats; Nilsson, Dag; Antoni, Gunnar Other Names: Zaidi Habib Academic Editor. Journal: International journal of molecular imaging Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology. Issue 6 (7th December 2020) Authors: Kawakatsu, Sonoko; Bruno, René; Kågedal, Matts; Li, Chunze; Girish, Sandhya; Joshi, Amita; Wu, Benjamin Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 6(2021) Page Start: 2493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study. (19th December 2018) Authors: Kirschbrown, Whitney P.; Wynne, Chris; Kågedal, Matts; Wada, Russ; Li, Hanbin; Wang, Bei; Nijem, Ihsan; Badovinac Crnjevic, Tanja; Gasser, Helena; Heeson, Sarah; Eng‐Wong, Jennifer; Garg, Amit Journal: Journal of clinical pharmacology Issue: Volume 59:Number 5(2019) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Estimation of drug receptor occupancy when non‐displaceable binding differs between brain regions – extending the simplified reference tissue model. (1st June 2015) Authors: Kågedal, Matts; Varnäs, Katarina; Hooker, Andrew C.; Karlsson, Mats O. Journal: British journal of clinical pharmacology Issue: Volume 80:Number 1(2015:Jul.) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates. (17th November 2020) Authors: Li, Chunze; Chen, Shang‐Chiung; Chen, Yuan; Girish, Sandhya; Kågedal, Matts; Lu, Dan; Lu, Tong; Samineni, Divya; Jin, Jin Y. Other Names: Arya Vikram guestEditor.; Venkatakrishnan Karthik guestEditor. Journal: Journal of clinical pharmacology Issue: Volume 60(2020)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?. Issue 5 (8th July 2021) Authors: Liao, Michael Z.; Lu, Dan; Kågedal, Matts; Miles, Dale; Samineni, Divya; Liu, Stephanie N.; Li, Chunze Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 5(2021) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetic–pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA). (20th November 2014) Authors: Maringwa, John; Kågedal, Matts; Hamrén, Ulrika Wählby; Martin, Paul; Cox, Eugène; Hamrén, Bengt Journal: Journal of clinical pharmacology Issue: Volume 55:Number 3(2015:Mar.) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Time‐to‐Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine‐Citrulline‐Monomethylauristatin E Antibody–Drug Conjugates. (10th July 2019) Authors: Kågedal, Matts; Samineni, Divya; Gillespie, William R.; Lu, Dan; Fine, Bernard M.; Girish, Sandhya; Li, Chunze; Jin, Jin Y. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 8(2019) Page Start: 606 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗